COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,386 Articles (22,816 medRxiv, 8,570 bioRxiv)

Most recent first Previous |  Page 1795: Articles 17941-17950  | Next

Antigen production and development of an indirect ELISA based on the nucleocapsid protein to detect human SARS-CoV-2 seroconversion
Conzentino, M. d. S., Forchhammer, K., Souza, E. M., Pedrosa, F. d. O., Nogueira, M. B., Raboni, S. M., Rego, F. G. M., Zanette, D. L., Aoki, M. N., Nardin, J. M., Fornazari, B., Morales, H. M. P., Celedon, P. A. F., Lima, C. V. P., Mattar, S. B., Lin, V. H., Morello, L. G., Marchini, F. K., Bueno, L. B., Reis, R. A., Huergo, L.
10.1101/2021.02.19.21252100 — Posted: 2021-02-23
Reproduction as a Means of Evaluating Policy Models: A Case Study of a COVID-19 Simulation
Chattoe-Brown, E., Gilbert, P. N., Robertson, D. A., Watts, C. J.
10.1101/2021.01.29.21250743 — Posted: 2021-02-23
International travel in times of the COVID-19 pandemic: Evidence from German school breaks
Backhaus, A.
10.1101/2021.02.19.21252062 — Posted: 2021-02-23
Targeting CoV-2 Spike RBD and ACE-2 Interaction with Flavonoids of Anatolian Propolis by in silico and in vitro Studies in terms of possible COVID-19 therapeutics
GULER, H. I., AY SAL, F., CAN, Z., KARA, Y., BELDUZ, A. O., CANAKCI, S., KOLAYLI, S.
10.1101/2021.02.22.432207 — Posted: 2021-02-22
Modeling SARS-CoV-2 infection and its individual differences with ACE2-expressing human iPS cells
Sano, E., Sakamoto, A., Mimura, N., Hirabayashi, A., Muramoto, Y., Noda, T., Yamamoto, T., Takayama, K.
10.1101/2021.02.22.432218 — Posted: 2021-02-22
Experimental evidence for enhanced receptor binding by rapidly spreading SARS-CoV-2 variants
Laffeber, C., de Koning, K., Kanaar, R., Lebbink, J.
10.1101/2021.02.22.432357 — Posted: 2021-02-22
Reanalysis of deep-sequencing data from Austria points towards a small SARS-COV-2 transmission bottleneck on the order of one to three virions
Martin, M. A., Koelle, K.
10.1101/2021.02.22.432096 — Posted: 2021-02-22
Acquisition of the L452R mutation in the ACE2-binding interface of Spike protein triggers recent massive expansion of SARS-Cov-2 variants
Tchesnokova, V., Kulakesara, H., Larson, L., Bowers, V., Rechkina, E., Kisiela, D., Sledneva, Y., Choudhury, D., Maslova, I., Deng, K., Kutumbaka, K., Geng, H., Fowler, C., Ralston, J. D., Greene, D., Samadpour, M., Sokurenko, E. V.
10.1101/2021.02.22.432189 — Posted: 2021-02-22 Discussion: Offsite
High-Throughput, Single-Copy Sequencing Reveals SARS-CoV-2 Spike Variants Coincident with Mounting Humoral Immunity during Acute COVID-19
Ko, S. H., Bayat Mokhtari, E., Mudvari, P., Stein, S., Stringham, C. D., Wagner, D., Ramelli, S., Ramirez-Benitez, M. J., Strich, J. R., Davey, R. T., Zhou, T., Misasi, J., Kwong, P. D., Chertow, D. S., Sullivan, N. J., Boritz, E. A.
10.1101/2021.02.21.432184 — Posted: 2021-02-22
The interspecific fungal hybrid Verticillium longisporum displays sub-genome-specific gene expression
Depotter, J., van Beveren, F., Rodriguez-Moreno, L., Kramer, M., Chavarro Carrero, E., Lorencini Fiorin, G., van den Berg, G., Wood, T., Thomma, B., Seidl, M.
10.1101/341636 — Posted: 2021-02-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).